NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Switch to English

10456	Sociétés
219587	Mots-clés
148969	Articles
116111	Communiqués

Accueil
Sociétés
NanoViricides, Inc.

BRÈVE

publiée le 15/05/2026 à 14:40, il y a 11 jours 2 heures

NanoViricides Announces $2 Million Direct Offering

NanoViricides Securities Offering Direct Investment Institutional Investor Antiviral Technology
COMMUNIQUÉ DE PRESSE

publié le 15/05/2026 à 14:35, il y a 11 jours 2 heures

NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering
NanoViricides, Inc. announces a registered direct offering of common shares and warrants to a fundamental institutional investor for gross proceeds of approximately US$2 million. D. Boral Capital LLC acts as the exclusive placement agent for the Offering

NanoViricides Securities Purchase Agreement Registered Direct Offering D. Boral Capital LLC Fundamental Institutional Investor
BRÈVE

publiée le 15/05/2026 à 14:05, il y a 11 jours 2 heures

NanoViricides fait état de progrès dans le développement du NV-387 dans son dernier document déposé auprès de la SEC.

NanoViricides NV-387 Essai De Phase II Médicament Orphelin Traitement De La Variole Du Singe
BRÈVE

publiée le 15/05/2026 à 14:05, il y a 11 jours 2 heures

NanoViricides Reports Progress on NV-387 in Latest SEC Filing

NanoViricides NV-387 Phase II Trial Orphan Drug Monkeypox Treatment
COMMUNIQUÉ DE PRESSE

publié le 15/05/2026 à 14:00, il y a 11 jours 2 heures

NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II
NanoViricides, Inc. files Quarterly Report on Form 10-Q with the SEC. NV-387 advances in Phase II trial for Measles, MPox, and Smallpox treatments. Financial updates disclosed

NV-387 Form 10-Q NanoViricides Inc. Phase II Trial Financial Update
BRÈVE

publiée le 11/05/2026 à 14:35, il y a 15 jours 2 heures

NanoViricides Highlights Need for Broad-Spectrum Antivirals Post-Hantavirus Incident

NanoViricides NV-387 Broad-spectrum Antiviral Hantavirus MV Hondius
BRÈVE

publiée le 11/05/2026 à 14:35, il y a 15 jours 2 heures

NanoViricides souligne le besoin d'antiviraux à large spectre après l'incident du hantavirus

NanoViricides NV-387 Antiviral À Large Spectre Hantavirus MV Hondius
COMMUNIQUÉ DE PRESSE

publié le 11/05/2026 à 14:30, il y a 15 jours 2 heures

Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
NanoViricides, Inc. highlights the need for a revolutionary antiviral drug like NV-387 as response to Andes hantavirus incident on a cruise ship, emphasizing potential global epidemic risk

NV-387 NanoViricides Inc. Antiviral Drug Andes Hantavirus Global Epidemic
BRÈVE

publiée le 04/05/2026 à 14:35, il y a 22 jours 2 heures

Le NV-387 de NanoViricides obtient la désignation de médicament orphelin pour le traitement de la rougeole

NanoViricides NV-387 Désignation De Médicament Orphelin FDA Américaine Traitement De La Rougeole
BRÈVE

publiée le 04/05/2026 à 14:35, il y a 22 jours 2 heures

NanoViricides' NV-387 Receives Orphan Drug Designation for Measles Treatment

NanoViricides NV-387 Orphan Drug Designation Measles Treatment US FDA

Les Echos

Publié le 26/05/2026 à 15:00, il y a 1 heure 58 minutes

Besluiten Gewone en Buitengewone Algemene Vergaderingen
Publié le 26/05/2026 à 15:00, il y a 1 heure 58 minutes

Resolutions Ordinary and Extraordinary General Meetings
Publié le 26/05/2026 à 07:59, il y a 8 heures 59 minutes

Saint-Gobain signe un accord de cession de son activité de distribution de carrelage dans les pays nordiques
Publié le 26/05/2026 à 07:59, il y a 8 heures 59 minutes

Saint-Gobain has signed an agreement for the sale of its Tiles Distribution business in the Nordics
Publié le 25/05/2026 à 18:00, il y a 22 heures 58 minutes

Déclaration des transactions sur actions propres réalisées du 18/05/2026 au 24/05/2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 26/05/2026 à 14:30, il y a 2 heures 28 minutes

Klondike Gold Announces 2026 Diamond Drilling Program Underway to Update and Expand Gold Mineral Resources
Publié le 26/05/2026 à 14:30, il y a 2 heures 28 minutes

Predictiv AI Announces Strategic Healthcare Partnership and CloudRep AI Integration with Clinicmaster Following Successful Multi-Clinic Pilot Deployments
Publié le 26/05/2026 à 14:30, il y a 2 heures 28 minutes

In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides
Publié le 26/05/2026 à 14:15, il y a 2 heures 43 minutes

Worksport (NASDAQ:WKSP) Secures U.S. Patent For 'Industry-First' Zerofrost Heat Pump Through Its Subsidiary, Terravis Energy
Publié le 26/05/2026 à 14:00, il y a 2 heures 58 minutes

Ameriwest Critical Metals Provides Q2 2026 Corporate Update and Announces Live CEO Investor Webinar

Voir tout ACCESSWIRE

EQS Group

Publié le 26/05/2026 à 16:30, il y a 27 minutes

M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
Publié le 26/05/2026 à 16:15, il y a 43 minutes

R. STAHL AG Management Board member Dr. Claus Bischoff resigns from his office as Management Board member at his own request and for personal reasons and will leave by mutual agreement as of 31 May 20
Publié le 26/05/2026 à 16:03, il y a 55 minutes

EQS-Adhoc: R. Stahl AG: Dr. Claus Bischoff resigns from his office as member of the Management Board of R. STAHL Aktiengesellschaft with immediate effect and will leave the company as of 31 May 2026.
Publié le 26/05/2026 à 16:01, il y a 57 minutes

EQS-Adhoc: Tempton Personaldienstleistungen GmbH announces full redemption of bonds and the exercise of the early redemption option
Publié le 26/05/2026 à 15:37, il y a 1 heure 20 minutes

FGC plans regional rail transport in Catalonia with IVU.rail